Invest 30 Million with an Annual Output of 50 Million! Tianjin Empecs Medical Device’s Capital Increase and Production Expansion Project Launched in Bincheng!
작성자 EMPECS
날짜 2025-06-27 17:06:30
조회수 27
Invest 30 Million with an Annual Output of 50 Million! Tianjin Empecs Medical Device’s Capital Increase and Production Expansion Project Launched in Bincheng!
In recent years, Zhaishang Street has continued to optimize the business environment, cultivate fertile industrial ground, and yield fruitful results. Tianjin Empecs Medical Device Co., Ltd., as a key foreign-funded enterprise and national high-tech enterprise in the jurisdiction, has made outstanding contributions to tax revenue growth and employment improvement.
In 2024, with an annual output value of more than 400 million yuan and tax payments exceeding 14 million yuan, it has become a strong pillar of the street’ s economy. In 2025, the company’ s layout will be expanded, and on June 27, the R&D and production project for a Continuous Glucose Monitoring (CGM) System, with an investment of 30 million yuan, was officially launched. This marks a solid step forward in the high- quality development of advanced manufacturing in the district.
On June 27, the groundbreaking ceremony for Tianjin Empecs Medical Device Co ., Ltd .’s CGM System Production Workshop Project was held on Zhaishang Street, Binhai New Area. Attendees included Wang Huisheng, Secretary of the Party Working Committee of Zhaishang Street, Yang Hongyuan, Deputy Director of the Street Office, and Zhang Rongxiang, Chairman of Tianjin Empecs Medical Device Co., Ltd.
At the event, colorful flags were displayed and construction equipment was neatly arranged. Chairman Zhang Rongxiang said in his speech: “Today is a milestone for the development of Empecs. Standing on this 4,000-square-meter factory base that will be built, I am full of expectations for the future. In the early 90s, I first came to China with a dream of a small factory with only a dozen people. After unremitting struggle, the company has gradually grown. In the early 2000s, we decided to invest in the blood glucose business. Even in today’s globally uncertain economy, I remain confident. This time, together with hundreds of employees who support me side by side, we will increase capital and expand production here in Binchengzhai, strengthen our confidence, and move forward bravely towards a better future!”
As the salute resounded through the sky, the scene was filled with warm applause as street and company leaders held shovels to turn the first soil for the project. This groundbreaking was not only a celebration of the project’s successful start but also an expression of hope for future cooperation and mutual success.
Hongyuan, Deputy Director of Zhaishang Street Office, said: “Tianjin Empecs Medical Device’ s investment of 30 million yuan in capital increase and production expansion is a strategic decision to deepen its presence in the Bincheng market, bringing benefits to the district in terms of tax revenue and employment. Zhaishang Street will continue to provide high- quality business services, comprehensively support enterprises, follow up throughout the construction, completion, and production phases, and create a favorable environment for companies to thrive here with more pragmatic measures.”
It is understood that Tianjin Empecs Medical Device Co., Ltd., as a Korean-funded enterprise since 1992, has created employment for over 1,000 people in the jurisdiction. Its independently developed blood glucose meters and other products have obtained technical patents in China, South Korea, the United States, and other countries , selling well both domestically and internationally.
This 30 million yuan investment in R&D and production of an embedded Continuous Glucose Monitoring (CGM) System will provide daily blood glucose monitoring for diabetic patients to facilitate the formulation of reasonable treatment programs. Annual production is expected to reach 100,000 sets, with an annual output value of 50 million yuan.
Looking ahead, Zhaishang Street will continue to focus on the needs of all aspects of project construction with pragmatic measures, continuously optimize the business environment, provide more efficient and dedicated services for enterprises, and create a new benchmark for a thriving business ecology.